Lafadofensine
Lafadofensine, also known as -N,''N-bis''pyrrolidin-3-amine, is a drug described as an antidepressant which has not been marketed at this time. It is said to act as a serotonin–norepinephrine–dopamine reuptake inhibitor. The drug was first described by 2010 and its was proposed by 2021.